Clinical Trial Update: RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin [NA]

View source ↗

Summary

A clinical trial is evaluating RFMN in combination with a 1927 nm Thulium laser to treat photoaged skin, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photoaging

Drugs mentioned

• RFMN

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Photoaging | NA | Status: RECRUITING